Similar results are seen in data from the Hematopoietic Cell Transplantation and Cellular Therapy Survey of the European Society for Blood and Marrow Transplantation (EBMT) in 2021, showing an increasing trend in haplo-identical HSCT starting from the year 2010 onwards [ 4 ].
← all excerpts
Real-World Challenges of Haplo-Identical Hematopoietic Stem Cell Transplant in a Developing Country: A Single Center Experience
1
—
—